Published in Medicina (Kaunas) on January 01, 2007
Diagnostic values of Helicobacter pylori diagnostic tests: stool antigen test, urea breath test, rapid urease test, serology and histology. J Res Med Sci (2011) 0.88
Clinical Validation of an Office-Based C-UBT (Heliprobe) for H. pylori Diagnosis in Iranian Dyspeptic Patients. Gastroenterol Res Pract (2011) 0.84
The effect of helicobacter pylori eradication on liver fat content in subjects with non-alcoholic Fatty liver disease: a randomized open-label clinical trial. Hepat Mon (2013) 0.81
Quadruple therapy for eradication of Helicobacter pylori. World J Gastroenterol (2013) 0.78
Diagnostic Methods of Helicobacter pylori Infection for Epidemiological Studies: Critical Importance of Indirect Test Validation. Biomed Res Int (2016) 0.78
High rate of Helicobacter pylori reinfection in Lithuanian peptic ulcer patients. World J Gastrointest Pathophysiol (2016) 0.75
Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease. Nature (2012) 16.13
Meta-analysis identifies 29 additional ulcerative colitis risk loci, increasing the number of confirmed associations to 47. Nat Genet (2011) 7.98
The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Definitions and diagnosis. J Crohns Colitis (2010) 3.97
Omega-3 free fatty acids for the maintenance of remission in Crohn disease: the EPIC Randomized Controlled Trials. JAMA (2008) 3.09
Twin study indicates loss of interaction between microbiota and mucosa of patients with ulcerative colitis. Gastroenterology (2011) 2.52
Association between variants of PRDM1 and NDP52 and Crohn's disease, based on exome sequencing and functional studies. Gastroenterology (2013) 1.83
Genome-wide association study for ulcerative colitis identifies risk loci at 7q22 and 22q13 (IL17REL). Nat Genet (2010) 1.72
Interleukin-1B and interleukin-1 receptor antagonist gene polymorphisms are not associated with premalignant gastric conditions: a combined haplotype analysis. Eur J Gastroenterol Hepatol (2010) 1.52
Once-daily budesonide MMX in active, mild-to-moderate ulcerative colitis: results from the randomised CORE II study. Gut (2013) 1.37
Emergence of tetracycline resistance in Helicobacter pylori: multiple mutational changes in 16S ribosomal DNA and other genetic loci. Antimicrob Agents Chemother (2002) 1.27
Rationale in diagnosis and screening of atrophic gastritis with stomach-specific plasma biomarkers. Scand J Gastroenterol (2012) 1.18
Efficacy and safety of ursodeoxycholic acid versus cholestyramine in intrahepatic cholestasis of pregnancy. Gastroenterology (2005) 1.15
Intrahepatic cholestasis of pregnancy-current achievements and unsolved problems. World J Gastroenterol (2008) 1.01
The validity of a biomarker method for indirect detection of gastric mucosal atrophy versus standard histopathology. Dig Dis Sci (2009) 0.96
Efficacy of the natural antioxidant astaxanthin in the treatment of functional dyspepsia in patients with or without Helicobacter pylori infection: A prospective, randomized, double blind, and placebo-controlled study. Phytomedicine (2008) 0.92
Genetic control of global gene expression levels in the intestinal mucosa: a human twin study. Physiol Genomics (2009) 0.91
Influence of wrap length on the effectiveness of Nissen and Toupet fundoplication: a prospective randomized study. Surg Endosc (2008) 0.90
Disease-specific health-related quality of life and its determinants in liver cirrhosis patients in Lithuania. World J Gastroenterol (2006) 0.90
Hepatic venous pressure gradient measurement in patients with liver cirrhosis: a correlation with disease severity and variceal bleeding. Medicina (Kaunas) (2009) 0.89
An unusual case of bleeding from stomach due to a giant diospyrobezoar. Medicina (Kaunas) (2009) 0.88
NOD2, IL23R and ATG16L1 polymorphisms in Lithuanian patients with inflammatory bowel disease. World J Gastroenterol (2010) 0.87
Initial disease course and treatment in an inflammatory bowel disease inception cohort in Europe: the ECCO-EpiCom cohort. Inflamm Bowel Dis (2014) 0.87
Predictors of premature delivery in patients with intrahepatic cholestasis of pregnancy. World J Gastroenterol (2007) 0.86
Helicobacter pylori genotypes in Lithuanian patients with chronic gastritis and duodenal ulcer. Medicina (Kaunas) (2008) 0.86
3g mesalazine granules are superior to 9mg budesonide for achieving remission in active ulcerative colitis: a double-blind, double-dummy, randomised trial. J Crohns Colitis (2010) 0.85
Evolution of Helicobacter pylori susceptibility to antibiotics during a 10-year period in Lithuania. APMIS (2012) 0.85
Gastric inflammatory markers and interleukins in patients with functional dyspepsia, with and without Helicobacter pylori infection. FEMS Immunol Med Microbiol (2005) 0.85
Replication study of ulcerative colitis risk loci in a Lithuanian-Latvian case-control sample. Inflamm Bowel Dis (2013) 0.85
Gastric inflammatory markers and interleukins in patients with functional dyspepsia treated with astaxanthin. FEMS Immunol Med Microbiol (2007) 0.84
Perceptual and acoustic characteristics of voice changes in reflux laryngitis patients. J Voice (2005) 0.84
Costs and resource utilization for diagnosis and treatment during the initial year in a European inflammatory bowel disease inception cohort: an ECCO-EpiCom Study. Inflamm Bowel Dis (2015) 0.84
Influence of NADPH oxidase on inflammatory response in primary intestinal epithelial cells in patients with ulcerative colitis. BMC Gastroenterol (2013) 0.84
Assessment of heterogeneity between European Populations: a Baltic and Danish replication case-control study of SNPs from a recent European ulcerative colitis genome wide association study. BMC Med Genet (2011) 0.83
Laryngeal examination is superior to endoscopy in the diagnosis of the laryngopharyngeal form of gastroesophageal reflux disease. Scand J Gastroenterol (2006) 0.83
Increased prevalence of subclinical hypothyroidism in common bile duct stone patients. J Clin Endocrinol Metab (2007) 0.82
Combined serum IgG response to Helicobacter pylori VacA and CagA predicts gastric cancer. FEMS Immunol Med Microbiol (2007) 0.81
Prevalence of C282Y, H63D, and S65C mutations in hereditary HFE-hemochromatosis gene in Lithuanian population. Ann Hematol (2011) 0.81
Precancerous gastric conditions in high Helicobacter pylori prevalence areas: comparison between Eastern European (Lithuanian, Latvian) and Asian (Taiwanese) patients. Medicina (Kaunas) (2007) 0.81
Acute liver failure in Lithuania. Medicina (Kaunas) (2008) 0.81
Interobserver variation in assessment of gastric premalignant lesions: higher agreement for intestinal metaplasia than for atrophy. Eur J Gastroenterol Hepatol (2013) 0.81
Common Genetic Variants of PSCA, MUC1 and PLCE1 Genes are not Associated with Colorectal Cancer. Asian Pac J Cancer Prev (2015) 0.81
Pantoprazole 20 mg on demand is effective in the long-term management of patients with mild gastro-oesophageal reflux disease. Eur J Gastroenterol Hepatol (2005) 0.80
[Retrospective analysis of case histories of patients with ulcerative colitis and Crohn's disease]. Medicina (Kaunas) (2003) 0.80
The humoral immuneresponse to Helicobacter pylori infection in children with gastrointestinal symptoms. FEMS Immunol Med Microbiol (2005) 0.80
Prognostic factors for short and long-term survival in patients selected for liver transplantation. Medicina (Kaunas) (2005) 0.79
A 1 year follow-up study of the consequences of Helicobacter pylori eradication in duodenal ulcer patients: unchanged frequency of erosive oesophagitis and decreased prevalence of non-erosive gastro-oesophageal reflux disease. Eur J Gastroenterol Hepatol (2004) 0.79
Gastric plasma biomarkers and Operative Link for Gastritis Assessment gastritis stage. Eur J Gastroenterol Hepatol (2011) 0.79
Correction: Analysis of Deregulated microRNAs and Their Target Genes in Gastric Cancer. PLoS One (2015) 0.78
Interferon alpha-2b in combination with ribavirin for the treatment of chronic hepatitis C: assessment of virological, biochemical and histological treatment response. Medicina (Kaunas) (2004) 0.78
Immune system alterations in patients with inflammatory bowel disease during remission. Medicina (Kaunas) (2008) 0.78
Fatty acids of erythrocyte membrane in acute pancreatitis patients. World J Gastroenterol (2013) 0.77
[Dietary characteristics of patients with inflammatory bowel diseases]. Medicina (Kaunas) (2006) 0.77
Helicobacter pylori antibodies and gastric cancer: a gender-related difference. FEMS Immunol Med Microbiol (2005) 0.77
Gastroesophageal reflux disease after Helicobacter pylori eradication in gastric ulcer patients: a one-year follow-up study. Medicina (Kaunas) (2008) 0.77
High frequency of the c.3207C>A (p.H1069Q) mutation in ATP7B gene of Lithuanian patients with hepatic presentation of Wilson's disease. World J Gastroenterol (2008) 0.77
What Bizzozero never could imagine - Helicobacter pylori today and tomorrow. Medicina (Kaunas) (2003) 0.77
Risk factors for erosive esophagitis and Barrett's esophagus in a high Helicobacter pylori prevalence area. Medicina (Kaunas) (2011) 0.76
Liver diseases unique to pregnancy. Medicina (Kaunas) (2008) 0.76
Performance of routine Helicobacter pylori tests in patients with atrophic gastritis. J Gastrointestin Liver Dis (2011) 0.76
Improvement of liver histopathology in patients with hepatitis C after interferon and ribavirin combination therapy. Medicina (Kaunas) (2004) 0.76
[Control of viral hepatitis in Lithuanian hemodialysis centers in 1997-2001]. Medicina (Kaunas) (2003) 0.75
Diagnostic sensitivity and specificity of laryngoscopic signs of reflux laryngitis. Medicina (Kaunas) (2008) 0.75
[Diagnostics of laryngopharyngeal form of gastroesophageal reflux disease for adults (Lithuanian clinical practice guidelines)]. Medicina (Kaunas) (2007) 0.75
Long-term dynamics of gastric biomarkers after eradication of Helicobacter pylori infection. Eur J Gastroenterol Hepatol (2015) 0.75
De novo erosive esophagitis in duodenal ulcer patients related to pre-existing reflux symptoms, smoking, and patient age, but not to Helicobacter pylori eradication: a one-year follow-up study. Medicina (Kaunas) (2010) 0.75
[Modern attitude towards management of laryngopharyngeal form of gastroesophageal reflux disease. Lithuanian clinical practice guidelines for adults]. Medicina (Kaunas) (2007) 0.75